China Antiepileptic Drug Market: Segmented by Generation (First, Second and Third), Distribution channels (Hospital, Retail and Online) - Growth, Trends, and Forecasts (2019 2028)
- Published Date: 2022-12-28
- Report ID: 139832
- Pages: 200
-
Format:
Report Overview
The China Antiepileptic Drug market size stood at around USD XX billion in 2019 and is projected to reach USD 1.16 billion by 2028, exhibiting a CAGR of XX% during the forecast period.
The prevalence of epilepsy in China is 7%, and the prevalence of active epilepsy is 4.6%. In addition, there is a large gap in the treatment of epilepsy, which is about 63%. Based on this, it is estimated that the current epilepsy number of patients is more than 9 million, of which more than 6.4 million are patients with active epilepsy.
Market Drivers
Increasing incidence of neurological disorder and rising geriatric population are some factors driving the growth of Antiepileptic drugs market. Increasing advancement of drug modification and increasing number of available Antiepileptic drugs are some factors driving the growth of the market. Moreover, advancement in drugs provide small effects on liver metabolism that converts into a lower rate of side effects further contributing to the growth of Antiepileptic Drugs Market. Active government support and Investments are expediting the market growth. The R&D is now focused on the development of target specific drugs.
1. China Antiepileptic Drug Market Overview......................................................
A. Market Size
2. Market Growth Drivers.........................................................................................
A. Increasing incidence of neurological disorders and rising geriatric population
B. Advancement in drug modification and government support
3. Type of AEDs..........................................................................................................
A. Valproic acid
B. Lamotrigine
C. Topiramate
D. Zonisamide
E. Levetiracetam
F. Clonazepam
G. Rufinamide
4. China Antiepileptic Drugs Market Segmentation...........................................
A. By Generation (drug class)
I. First Generation
II. Second Generation
III. Third Generation
B. By Distribution channel
I. Hospital
II. Retail
III. Online
5. Antiepileptic Drugs Major Products Market Share........................................
A. Key Findings
B. Market Analysis, Insights and Forecast By Drug Type
6. Competitive Landscape........................................................................................
A. Major Players
B. Products in Pipeline
7. Key Company Profiles..........................................................................................
A. Pfizer Inc., Company overview, Product & Services, Strategies & Financials
B. Eisai Co. Ltd., Company overview, Product & Services, Strategies & Financials
C. G.W. Pharmaceuticals Company, Product & Services, Strategies & Financials
8. Healthcare Policies and Regulatory Landscape..............................................
A. Policy changes and Reimbursement scenario
9. Factors Driving Future Growth...........................................................................
A. New Trends and Development of Antiepileptic Drug market
B. Future Opportunities
10. Conclusion
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
